These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36378340)

  • 1. A diagnostic miRNA panel to detect recurrence of ovarian cancer through artificial intelligence approaches.
    Aghayousefi R; Hosseiniyan Khatibi SM; Zununi Vahed S; Bastami M; Pirmoradi S; Teshnehlab M
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):325-341. PubMed ID: 36378340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.
    Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Yamada T; Kudo M; Yue J; Sakuragi N
    J Exp Clin Cancer Res; 2016 Sep; 35(1):132. PubMed ID: 27596137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.
    Tang W; Jiang Y; Mu X; Xu L; Cheng W; Wang X
    Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.
    Xu H; Mao HL; Zhao XR; Li Y; Liu PS
    J Ovarian Res; 2020 Mar; 13(1):31. PubMed ID: 32192508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A.
    Wang J; Liu L
    J Ovarian Res; 2021 Nov; 14(1):165. PubMed ID: 34798882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of key molecules in miRNA-mRNA regulatory network associated with high-grade serous ovarian cancer recurrence using bioinformatic analysis].
    Zhang P; He M; Zeng Y; Cai X
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jan; 43(1):8-16. PubMed ID: 36856205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer.
    Berkel C; Cacan E
    Hum Cell; 2021 May; 34(3):862-877. PubMed ID: 33576947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence.
    Delfino KR; Rodriguez-Zas SL
    PLoS One; 2013; 8(3):e58608. PubMed ID: 23554906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miR-4443 and miR-5195-3p in ovarian cancer tissue contributes to metastasis and tumorigenesis.
    Ebrahimi SO; Reiisi S
    Arch Gynecol Obstet; 2019 May; 299(5):1453-1458. PubMed ID: 30810880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R.
    Zhang Y; Huang S; Guo Y; Li L
    Biomed Pharmacother; 2018 Oct; 106():1357-1363. PubMed ID: 30119207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence diverse miRNAs converge to induce mesenchymal-to-epithelial transition in ovarian cancer cells through direct and indirect regulatory controls.
    Zhang M; Jabbari N; Satpathy M; Matyunina LV; Wang Y; McDonald LD; McDonald JF
    Cancer Lett; 2019 Sep; 459():168-175. PubMed ID: 31163194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma.
    Tuncer SB; Erdogan OS; Erciyas SK; Saral MA; Celik B; Odemis DA; Turkcan GK; Yazici H
    J Ovarian Res; 2020 Aug; 13(1):99. PubMed ID: 32854743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of miR-9 and miR-223 in recurrent ovarian cancer.
    Laios A; O'Toole S; Flavin R; Martin C; Kelly L; Ring M; Finn SP; Barrett C; Loda M; Gleeson N; D'Arcy T; McGuinness E; Sheils O; Sheppard B; O' Leary J
    Mol Cancer; 2008 Apr; 7():35. PubMed ID: 18442408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
    Koutsaki M; Spandidos DA; Zaravinos A
    Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-205-3p Functions as a Tumor Suppressor in Ovarian Carcinoma.
    Qiao B; Wang Q; Zhao Y; Wu J
    Reprod Sci; 2020 Jan; 27(1):380-388. PubMed ID: 32046433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircRNA FGFR3 induces epithelial-mesenchymal transition of ovarian cancer by regulating miR-29a-3p/E2F1 axis.
    Zhou J; Dong ZN; Qiu BQ; Hu M; Liang XQ; Dai X; Hong D; Sun YF
    Aging (Albany NY); 2020 Jul; 12(14):14080-14091. PubMed ID: 32668414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of miR-492 on migration, invasion, EMT and prognosis in ovarian cancer by targeting SOX7.
    Wang Z; Liu Y; Wang M; Zhao J
    J BUON; 2020; 25(2):797-804. PubMed ID: 32521870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
    Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
    J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
    Xue B; Li S; Jin X; Liu L
    BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
    Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B
    BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.